| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01B ANTIARRHYTHMICS, CLASS I AND III
C01BB Antiarrhythmics, class Ib
C01BB01 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
C05 VASOPROTECTIVES
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AD Local anesthetics
C05AD01 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
D DERMATOLOGICALS
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
D04AB Anesthetics for topical use
D04AB01 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BB Amides
N01BB02 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
R RESPIRATORY SYSTEM
R02 THROAT PREPARATIONS
R02A THROAT PREPARATIONS
R02AD Anesthetics, local
R02AD02 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01H LOCAL ANESTHETICS
S01HA Local anesthetics
S01HA07 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
S02 OTOLOGICALS
S02D OTHER OTOLOGICALS
S02DA Analgesics and anesthetics
S02DA01 Lidocaine
D00358 Lidocaine (JP17/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Anesthetics
Local Anesthetics
Lidocaine
D00358 Lidocaine (JP17/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
121 Local anesthetics
1214 Xylidines
D00358 Lidocaine (JP17/USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for urogenital organs and anus
30 Hemorrhoid drugs for external use
D00358 Lidocaine (JP17/USP/INN)
Agents for integumentary system
57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
D00358 Lidocaine (JP17/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Lidocaine
D00358 Lidocaine (JP17/USP/INN)
Pharmaceutical additives in Japan [BR:br08316]
Soothing agent
D00358 [001667] Lidocaine
Solubilizer
D00358 [001667] Lidocaine
Solubilization agent
D00358 [001667] Lidocaine
Solvent
D00358 [001667] Lidocaine
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Sodium channels
SCN1A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN2A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN3A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN4A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN5A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN8A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN9A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN10A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
SCN11A
D00358 Lidocaine (JP17/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00358 Lidocaine
D00358 Lidocaine injection
Drug classes of therapeutic agents [br08360.html]
Anesthetics, analgesics and anti-inflammatory drugs
D00358
 |
|---|
